IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Quartuccio, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 551
NA - Nord America 319
EU - Europa 221
SA - Sud America 210
AF - Africa 22
OC - Oceania 2
Totale 1.325
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 298
SG - Singapore 224
BR - Brasile 175
CN - Cina 95
VN - Vietnam 74
HK - Hong Kong 71
RU - Federazione Russa 38
DE - Germania 34
IT - Italia 34
FI - Finlandia 27
TR - Turchia 23
GB - Regno Unito 18
PL - Polonia 15
AR - Argentina 14
MX - Messico 13
BD - Bangladesh 12
NL - Olanda 10
ZA - Sudafrica 9
AT - Austria 8
EC - Ecuador 7
IN - India 7
CA - Canada 6
IQ - Iraq 6
JP - Giappone 6
MA - Marocco 6
EG - Egitto 5
ES - Italia 5
IE - Irlanda 5
PK - Pakistan 5
UA - Ucraina 5
UZ - Uzbekistan 5
CO - Colombia 4
ID - Indonesia 4
PE - Perù 4
SE - Svezia 4
VE - Venezuela 4
AZ - Azerbaigian 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
AU - Australia 2
FR - Francia 2
JO - Giordania 2
NP - Nepal 2
PH - Filippine 2
SA - Arabia Saudita 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BE - Belgio 1
BG - Bulgaria 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
Totale 1.325
Salva come PNG Salva come JPEG
Città #
Singapore 74
Hong Kong 71
Beijing 37
Ho Chi Minh City 33
Ashburn 27
Helsinki 23
Istanbul 20
Los Angeles 18
Hanoi 17
São Paulo 16
The Dalles 16
Warsaw 14
New York 13
Moscow 11
Munich 11
Redondo Beach 11
Romola 11
Buffalo 10
Nuremberg 9
Johannesburg 8
Curitiba 7
San Francisco 7
Shanghai 7
Biên Hòa 6
Brooklyn 6
Chicago 6
Tokyo 6
Dublin 5
Milan 5
Phoenix 5
Poplar 5
Rio de Janeiro 5
Tashkent 5
Brasília 4
Cairo 4
Charlotte 4
Dallas 4
Denver 4
Faisalabad 4
Lappeenranta 4
Porto Alegre 4
Salt Lake City 4
Stockholm 4
Amsterdam 3
Atlanta 3
Baghdad 3
Baku 3
Belo Horizonte 3
Brno 3
Bắc Ninh 3
Caxias do Sul 3
Chennai 3
Da Nang 3
Dhaka 3
Guangzhou 3
Haiphong 3
João Pessoa 3
Mexico City 3
Montreal 3
Pescara 3
Santa Clara 3
Vienna 3
Zhengzhou 3
Amman 2
Betim 2
Buenos Aires 2
Cleveland 2
Dalian 2
Don Torcuato 2
Falkenstein 2
Fortaleza 2
Frankfurt am Main 2
Hangzhou 2
Imbituba 2
Jacksonville 2
Jieyang 2
Lima 2
Magé 2
Manchester 2
Newark 2
Nova Iguaçu 2
Orlando 2
Osasco 2
Portoviejo 2
Providence 2
Querétaro 2
Quezon City 2
Quito 2
Rabat 2
Resistencia 2
Ribeirão Preto 2
Salvador 2
San Jose 2
Sorocaba 2
São José dos Campos 2
São Luís 2
Tampa 2
Tunis 2
Vitória de Santo Antão 2
Zurich 2
Totale 699
Salva come PNG Salva come JPEG
Nome #
Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study 74
Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey 72
Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD group 68
COVID-19 vaccination in autoimmune diseases (COVAD) Study: vaccine safety and tolerance in rheumatoid arthritis 66
Vaccine hesitancy decreases, long term concerns remain in myositis, rheumatic disease patients: A comparative analysis of the COVAD surveys 66
Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey 64
Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study 64
COVID-19 vaccine safety during the antenatal period in women with idiopathic inflammatory myopathies 63
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys 63
Breakthrough SARS‑CoV‑2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID‑19 Vaccination in Autoimmune Disease (COVAD) study 62
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveys 61
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study 61
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study 59
COVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey 58
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group 58
COVAD survey 2 long-term outcomes: unmet need and protocol 56
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey 55
Diagnostic pathway and treatment preferences for systemic lupus erythematosus: a physician-based discrete choice experiment 54
COVID-19 severity, breakthrough infections and vaccine safety in young individuals with autoimmune diseases: insights from the COVAD study 53
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study 48
COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study 47
Preferences for diagnostic pathways and treatment choice in systemic lupus erythematosus: a patient-based discrete choice experiment 40
Self-Reported Delayed Adverse Events and Flare Following COVID-19 Vaccination Among Patients With Autoimmune Rheumatic Disease (AIRD) in Malaysia: Results From the COVAD-2 Study 37
Totale 1.349
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.113
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.113
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202324 0 0 0 0 0 13 0 1 2 0 3 5
2023/2024133 3 5 11 12 2 14 4 1 29 3 5 44
2024/2025487 7 20 17 45 24 48 73 67 41 35 84 26
2025/2026705 85 199 94 144 137 46 0 0 0 0 0 0
Totale 1.349